1-Hydroxybenzotriazole → (1S,2S)-2-(4-{3-fluoro-4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-piperazine-1-carbonyl)-cyclopentanecarboxylic acid benzyl ester

HRID 1691948Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1691948
[F:1][C:2]1[CH:7]=[C:6]([N:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)[CH:5]=[CH:4][C:3]=1[NH:14][C:15]([C:17]1[N:18]=[C:19]([C:26]2[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=2)[O:20][C:21]=1[C:22]([F:25])([F:24])[F:23])=[O:16].C1(C2OC(C(F)(F)F)=C(C(O)=O)N=2)C=CC=CC=1.NC1C=CC(N2CCNCC2)=CC=1F.[CH2:64]([O:71][C:72]([C@H:74]1[CH2:78][CH2:77][CH2:76][C@@H:75]1[C:79](O)=[O:80])=[O:73])[C:65]1[CH:70]=[CH:69][CH:68]=[CH:67][CH:66]=1.ON1C2C=CC=CC=2N=N1.Cl.C(N=C=NCCCN(C)C)C.C(N(CC)C(C)C)(C)C>ClCCl>[CH2:64]([O:71][C:72]([C@H:74]1[CH2:78][CH2:77][CH2:76][C@@H:75]1[C:79]([N:11]1[CH2:10][CH2:9][N:8]([C:6]2[CH:5]=[CH:4][C:3]([NH:14][C:15]([C:17]3[N:18]=[C:19]([C:26]4[CH:27]=[CH:28][CH:29]=[CH:30][CH:31]=4)[O:20][C:21]=3[C:22]([F:25])([F:24])[F:23])=[O:16])=[C:2]([F:1])[CH:7]=2)[CH2:13][CH2:12]1)=[O:80])=[O:73])[C:65]1[CH:70]=[CH:69][CH:68]=[CH:67][CH:66]=1

Komponenten

9

Edukt 7

HCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27764382-Phenyl-5-(trifluoromethyl)-oxazole-4-carboxylic acidHCID 66738585(1s,2s)-2-(Benzyloxycarbonyl)cyclopentanecarboxylic acidHCID 66738689HCID 66738689, VerbindungHCID 66738698HCID 66738698, Verbindung

Produkt 1

HCID 66738142(1S,2S)-2-(4-{3-fluoro-4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-piperazine-1-carbonyl)-cyclopentanecarboxylic acid benzyl ester

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

A mixture of 2-phenyl-5-trifluoromethyl-oxazole-4-carboxylic acid (2-fluoro-4-piperazin-1-yl-phenyl)-amide (0.22 g, 0.5 mmol) prepared from 2-phenyl-5-trifluoromethyl-oxazole-4-carboxylic acid and 4-(4-amino-3-fluoro-phenyl)-piperazine using a procedure similar to the one described above, (1S,2S)-cyclopentane-1,2-dicarboxylic acid monobenzyl ester (0.26 g, 0.5 mmol), N-hydroxybenzotriazole (0.1 g, 0.74 mmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.14 g, 0.74 mmol), N,N-diisopropylethylamine (0.26 mL, 1.5 mmol) in anhydrous dichloromethane (4 mL) was stirred at room temperature for overnight. After the reaction, solvent was evaporated. The resulted mixture was mixed with water and extracted with ethyl acetate twice. The organic layers were collected, combined, washed with brine before dried over sodium sulfate, and then concentrated to give a solid. The crude product was purified by reverse phase HPLC (10%-80% acetonitrile in water) to gave (1S,2S)-2-(4-{3-fluoro-4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-piperazine-1-carbonyl)-cyclopentanecarboxylic acid benzyl ester as a yellow solid. LCMS calcd for C35H32F4N4O5 (m/e) 664, obsd 665 (M+H).

Aufarbeitung

  1. customAfter the reaction, solvent
  2. customwas evaporated
  3. additionThe resulted mixture was mixed with water
  4. extractionextracted with ethyl acetate twice
  5. customThe organic layers were collected
  6. washwashed with brine
  7. dry with materialbefore dried over sodium sulfate
  8. concentrationconcentrated
  9. customto give a solid
  10. customThe crude product was purified by reverse phase HPLC (10%-80% acetonitrile in water)

Quellen und Nachweise

ORD-Eintrag
ord-a5f3a26e7dd44810aaf4e95e0b2ad875
Quelldatensatz
uspto-grants-2012_04
Patentnummer
US08153644B2

Notizen zur Reaktion

Wird geladen…